OBX

Obsidian Therapeutics, Inc. - Common Stock (OBX)

About Obsidian Therapeutics, Inc. - Common Stock (OBX)

Obsidian Therapeutics Inc. engages in developing cell and gene therapies, particularly for the treatment of solid tumors and cancer. The company was founded on September 29, 2015 and is headquartered in Malvern, PA.

Details

Daily high
$13.90
Daily low
$13.07
Price at open
$13.07
52 Week High
$49.97
52 Week Low
$12.16
Market cap
822.8M
Dividend yield
-
Volume
228,988
Avg. volume
762,143
P/E ratio
.08

Obsidian Therapeutics, Inc. - Common Stock News

Details

Daily high
$13.90
Daily low
$13.07
Price at open
$13.07
52 Week High
$49.97
52 Week Low
$12.16
Market cap
822.8M
Dividend yield
-
Volume
228,988
Avg. volume
762,143
P/E ratio
.08